V ROSSII ZAREGISTRIROVAN PERVYY PATOGENETIChESKIY PREPARAT DLYa LEChENIYa PATsIENTOV S BOLEZN'Yu ITsENKO-KUShINGA


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Full Text

Restricted Access

About the authors

- -

References

  1. Инструкция по применению лекарственного препарата для медицинского применения СИГНИФОР®.
  2. National Endocrine and Metabolic Diseases Information Service. US National Institutes of Health. Cushing's Syndrome. Available at: http://endocrine.niddk.nih.gov/pubs/cushings/Cushings_Syndrome_FS.pdf. Accessed March 2012.
  3. Pedroncelli A. Medical Treatment of Cushing's Disease: Somatostatin Analogues and Pasireotide. Neuroendocrinology. 2010; 92(suppl. 1): 120-24.
  4. Colao A. A 12-Month Phase III Study of Pasireotide in Cushing's Disease. New Engl. J. Med. 2012; 366: 32-42.
  5. Tritos N., Biller B. Advances in Medical Therapies for Cushing's Syndrome. Discovery Medicine. 2012: 13(69): 171-79.
  6. Newell-Price J., et al. The Diagnosis and Differential Diagnosis of Cushing's Syndrome and Pseudo-Cushing's States. Endocrine Reviews.1998; 19(5): 647-72.
  7. Bertanga X., et al. Cushing's Disease. Best Practice & Research Clinical Endocrinology & Metabolism. 2009; 23: 607-23.
  8. European Commission. The Centralised Procedure. Available at: http://ec.europa.eu/health/ authorisation-procedurescentralised_en.htm. Accessed March 2012.
  9. European Medicines Agency. Committee for Orphan Medicinal Products. Public Summary of Positive Opinion for Orphan Designation of Pasireotide for the treatment of Cushing's Disease. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_ designation/2009/10/WC500006176.pdf. Accessed March 2012.
  10. Lindholm J., et al. Incidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study. J. Clin. Endocrinol. Metab. 2001; 86(1): 117-23.
  11. US National Institutes of Health. Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease. Available at: http://clinicaltrials.gov/ct2/show/NCT01374906. Accessed March 2012.
  12. Практическое руководство для врачей «Болезнь Иценко-Кушинга: клиника, диагностика, лечение» / Под редакцией И.И. Дедова, Г.А. Мельниченко М., 2012.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies